283 related articles for article (PubMed ID: 26130220)
1. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
[TBL] [Abstract][Full Text] [Related]
2. Relevance of biofilms in the pathogenesis of Shiga-toxin-producing Escherichia coli infection.
Villegas NA; Baronetti J; Albesa I; Polifroni R; Parma A; Etcheverría A; Becerra M; Padola N; Paraje M
ScientificWorldJournal; 2013; 2013():607258. PubMed ID: 24324376
[TBL] [Abstract][Full Text] [Related]
3. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
Kakoullis L; Papachristodoulou E; Chra P; Panos G
J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
[TBL] [Abstract][Full Text] [Related]
4. Shiga toxin-producing Escherichia coli (STEC) O22:H8 isolated from cattle reduces E. coli O157:H7 adherence in vitro and in vivo.
Martorelli L; Albanese A; Vilte D; Cantet R; Bentancor A; Zolezzi G; Chinen I; Ibarra C; Rivas M; Mercado EC; Cataldi A
Vet Microbiol; 2017 Sep; 208():8-17. PubMed ID: 28888654
[TBL] [Abstract][Full Text] [Related]
5. An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli.
Skinner C; Zhang G; Patfield S; He X
Antimicrob Agents Chemother; 2015 Sep; 59(9):5435-44. PubMed ID: 26100707
[TBL] [Abstract][Full Text] [Related]
6. Serotype, Shiga toxin (Stx) type, and antimicrobial resistance of Stx-producing Escherichia coli isolated from humans in Shizuoka Prefecture, Japan (2003-2007).
Hiroi M; Takahashi N; Harada T; Kawamori F; Iida N; Kanda T; Sugiyama K; Ohashi N; Hara-Kudo Y; Masuda T
Jpn J Infect Dis; 2012; 65(3):198-202. PubMed ID: 22627299
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic-mediated expression analysis of Shiga toxin 1 and 2 in multi-drug-resistant Shiga toxigenic Escherichia coli.
Rehman A; Andleeb S; Ullah SR; Mustafa Z; Gul D; Mehmood K
Folia Microbiol (Praha); 2021 Oct; 66(5):809-817. PubMed ID: 34143328
[TBL] [Abstract][Full Text] [Related]
8. Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin-producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan.
Mohsin M; Haque A; Ali A; Sarwar Y; Bashir S; Tariq A; Afzal A; Iftikhar T; Saeed MA
Foodborne Pathog Dis; 2010 Jan; 7(1):85-90. PubMed ID: 19785532
[TBL] [Abstract][Full Text] [Related]
9. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.
Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R
Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications.
Shaikh N; Tarr PI
J Bacteriol; 2003 Jun; 185(12):3596-605. PubMed ID: 12775697
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
[TBL] [Abstract][Full Text] [Related]
12. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
Ochoa TJ; Chen J; Walker CM; Gonzales E; Cleary TG
Antimicrob Agents Chemother; 2007 Aug; 51(8):2837-41. PubMed ID: 17526759
[TBL] [Abstract][Full Text] [Related]
13. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.
Zhang X; McDaniel AD; Wolf LE; Keusch GT; Waldor MK; Acheson DW
J Infect Dis; 2000 Feb; 181(2):664-70. PubMed ID: 10669353
[TBL] [Abstract][Full Text] [Related]
14. Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.
Oporto B; Esteban JI; Aduriz G; Juste RA; Hurtado A
Zoonoses Public Health; 2008; 55(2):73-81. PubMed ID: 18234025
[TBL] [Abstract][Full Text] [Related]
15. Virulence characteristics of Shiga toxin-producing Escherichia coli from raw meats and clinical samples.
Hoang Minh S; Kimura E; Hoang Minh D; Honjoh K; Miyamoto T
Microbiol Immunol; 2015 Mar; 59(3):114-22. PubMed ID: 25644201
[TBL] [Abstract][Full Text] [Related]
16. Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7.
Sheng L; Rasco B; Zhu MJ
Appl Environ Microbiol; 2016 Nov; 82(22):6531-6540. PubMed ID: 27590808
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Escherichia coli Isolates from humans, food, and farm and companion animals for presence of Shiga toxin-producing E. coli virulence markers.
Murinda SE; Nguyen LT; Landers TL; Draughon FA; Mathew AG; Hogan JS; Smith KL; Hancock DD; Oliver SP
Foodborne Pathog Dis; 2004; 1(3):178-84. PubMed ID: 15992278
[TBL] [Abstract][Full Text] [Related]
18. Effects of antimicrobials on Shiga toxin production in high-virulent Shiga toxin-producing Escherichia coli.
Ramstad SN; Taxt AM; Naseer U; Wasteson Y; Bjørnholt JV; Brandal LT
Microb Pathog; 2021 Mar; 152():104636. PubMed ID: 33242644
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7.
Bauwens A; Kunsmann L; Karch H; Mellmann A; Bielaszewska M
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28607018
[TBL] [Abstract][Full Text] [Related]
20. Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection.
Zhang Q; Donohue-Rolfe A; Krautz-Peterson G; Sevo M; Parry N; Abeijon C; Tzipori S
J Infect Dis; 2009 Feb; 199(4):486-93. PubMed ID: 19125676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
